BridgeBio Pharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
BridgeBio Pharma, Inc.
CIK #0001743881
EDGAR Form CIK 2011 - 2024
10-K [0001743881]
10-Q [0001743881]
3 [0001743881]
4 [0001743881]
5 [0001743881]
8-K [0001743881]
SC 13D [0001743881]
SC 13G [0001743881]
Form 13D/13G Filer Form 13D/13G Subject Filed
State Street Corp Bridgebio Pharma Inc [2023-02-08]
Vanguard Group Inc Bridgebio Pharma Inc [2021-02-10]
BlackRock Inc Bridgebio Pharma Inc [2021-02-05]
Eidos Therapeutics Inc Bridgebio Pharma Inc [2020-10-15]
Kumar Neil Bridgebio Pharma Inc [2020-02-14]
American International Group Inc Bridgebio Pharma Inc [2020-02-14]
Perceptive Advisors LLC Bridgebio Pharma Inc [2019-07-11]
KKR Genetic Disorder LP Bridgebio Pharma Inc [2019-07-10]
Viking Global Investors LP Bridgebio Pharma Inc [2019-07-08]
Bridgebio Pharma LLC Eidos Therapeutics Inc [2018-08-01]
Form 3/4/5 Subject 2011 - 2024
BridgeBio Pharma, Inc.
Stephenson Brian C
Kumar Neil
Homcy Charles J
McCormick Frank
Scheller Richard H
Cook Jennifer E.
Aguiar Eric
Valantine Hannah
Scott Randal W.
View All
Terms | Privacy | Guide
tony@aum13f.com